Rare Disease Therapeutics, Inc.
Rare Disease Therapeutics, Inc. (RDT) is America’s first exclusively orphan drug company committed to developing and marketing drugs for rare disorders. RDT distributes Purixan™ (mercaptopurine) oral suspension for treatment of patients with acute lymphoblastic leukemia as part of a combination regimen.